GYNECOLOGY
FRIDAY, NOVEMBER 25
08:30-10:00 |
HALL B | |
Capsule |
Dilemmas in daily care, which you have to deal with. Concerning adnexal masses and heavy menstrual bleeding | |
Chairpersons |
Justin Clark, UK |
|
What is the best referral policy for patients with an adnexal mass? |
||
Differentiating benign form malignant cyst >> how to recognize less common types of benign adnexal masses (struma ovarii/ Brenner tumor/ Sertoli Leydig cell) |
||
Treatment options in case of HMB with intramural fibroids? |
||
Is TLH really superior to abdominal hysterectomy ? |
||
Endometrial ablation under local anesthetics – is it feasible? |
10:00-10:20 | Coffee break, e-poster viewing and visit the exhibition | Exhibition Area |
10:20-11:50 |
HALL B | |
Capsule |
||
Chairpersons |
Peggy Geomini, Netherlands |
|
T-Shaped, Y-Shaped, Dysmorophic – a real reproductive problem or a new trend |
||
|
Debate: Dysmorphic Uterus, is it a real infertility problem? is the solution surgical? Pro:TBA It is a real infertility problem, but the solution is not surgical: Ben Mol, Australia Discussion |
|
Debate: Uterine septum in infertility: To treat or not to treat? |
||
Endometrial ablation under local anesthetics – is it feasible? |
11:50-12:00 | Break |
12:00-13:30 | HALL B |
13:30-14:30 | Lunch break, moderated e-posters and visit the exhibition | Exhibition Area |
14:30-16:30 | HALL B | |
Capsule |
|
|
Chairpersons |
Justin Clark, UK Dorenda van Dijken, Netherlands |
|
Endocrine disruptors in fertility |
||
Debate: Should ovarian tissue reimplantation be considered for all women to postpone menopause |
||
Postmenopausal hormone treatment and the risk for malignancies |
||
Can AMH predict menopause |
16:30-16:50 | Coffee break, e-poster viewing and visit the exhibition | Exhibition Area |
16:50-18:20 | HALL B | |
Capsule |
||
Chairpersons |
Christian Egarter, Austria TBA |
|
Debate: Should androgens be routinely added to menopause treatment Yes: Alessandra Graziottin, Italy No: Dorenda van Dijken, Netherlands Discussion |
||
Debate: Hormone therapy started in premature or early menopause, should be continued for life to prevent chronic diseases For: Nick Panay, UK Against: Mark Brincat, Malta Discussion |
||
Postmenopausal hormone treatment and the bone |